Psychiatr. praxi 2019; 20(2e) [Klin Farmakol Farm. 2018;32(2):13-19]
Patients with Parkinson´s disease (PN), a common neurodegenerative disorder, suffer not only from movement disorder, but also from mental disorders including behavioral disorders and psychosis. These disorders are closely related to dopaminergic treatment of PN. Despite knowledge of the clinical features of these disorders, many patients may not be diagnosed in time. Another issue are drug-drug interactions, because patients with PN are treated for associated diseases usually by other physicians, who may not always be aware, that the antiparkinsonian or antipsychotic drugs interact with other commonly prescribed drugs. This article introduces the medical public to these problems and shows possible solutions.
Published: June 1, 2019 Show citation